Healthcare Industry News: joint replacement
News Release - January 15, 2007
Portland Orthopaedicsí Equator Plus Cup Launched in USFirst Implant of Portlandís third product offering in Oregon, US
Oregon USA, January 15, 2007--(HSMN NewsFeed)-- Portland Orthopaedics Limited (ASX:PLD) first series of Equator Plus Cups have been implanted in Portland, Oregon today. The Equator Plus will be the third product Portland has available in the USA and is Portlandís second product release in the past 5 months following the successful launch of the M-COR stem in September 2006.
The Equator Plus launch and first implants are timely as the product will be available for exhibition at the Annual Meeting of the American Association of Orthopaedic Surgeons in San Diego from the 14th to the 18th of February 2007. The Academy has 24,000 members internationally and the Annual Meeting is the largest attended event in the US orthopaedics conference calendar.
The Equator Plus Cup is Portlandís third product now available for sale in the US and is used for primary (first time) and revision (second time) hip replacement patients. Portlandís Equator Plus hip cup is press fit into the pelvis and can be used with most other companiesí hip replacement stems. The Equator Plus has the advantage that the polyethylene liner insert has a solid metal backing, which potentially prevents wear particles from escaping through the screw holes at the back of the cup. Hence Portlandís product is expected to reduce the boneís exposure to wear particles and increase the life of the implant.
Portland now has products for use in both Primary and Revision surgery available for sale through its exclusive distributor, Plus Orthopedics Inc in the USA. Portlandís production capabilities are currently being expanded and more surgeons are expected to commence using the product as inventory is made available.
0410 343 667
0411 402 737
About Portland Orthopaedics : Listed on the ASX in December 2005, Portland (ASX:PLD) is a developer and manufacturer of specialist hip and knee joint replacements. Portlandís first product, the DTC Hip, was conceived in 1991 as standard hip implants proved inadequate in cases with substantial bone loss especially where a hip implant had already been inserted. Portlandís first hip implant was trialled in 1997 and so far more than 1,800 implants have been sold, the majority in the US and Australia.
Portland has regulatory approval to sell a range of primary, revision and tumour hip replacement products in the US, Europe, Australia, New Zealand and Israel. The core technologies are all patented and future applications include shoulders, ankles and other joints.
Source: Portland Orthopaedics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.